Medtronic's Recapturable CoreValve Evolut R System Receives CE Mark

Today Medtronic, Inc. (NYSE: MDT) reported that its next generation of the CoreValve transcatheter aortic valve has received the CE Mark and is now available in Europe and other countries that recognize the CE Mark. This new system offers greater accuracy, better fit, the ability to recapture and reposition the valve during deployment, and has the smallest sheath size (14F) curently availabe on the market.

Source: News from Angioplasty.Org - September 3, 2014 Category: Cardiology Source Type: news